[Abstract] [Full Text PDF] (in Japanese / 1760KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 103(11): 803-805, 2002


Feature topic

OPTION OF THE SURGICAL MODE FOR BREAST CANCER BASED ON THE EFFECT OF NEOADJVANT CHEMOTHERAPY

National Cancer Center Hospital, Breast Surgery Division, Tokyo, Japan

Takashi Fukutomi

Neoadjuvant chemotherapy has become standard treatment for breast cancer patients to avoid mastectomy in larger tumors. Neoadjuvant chemotherapy permits more breast-conserving surgery to be performed. The treatment outcome is favorable in women whose tumors show a complete pathological response. Histological grade, HER-2, p53, and hormone receptor status are significant predictive factors of a good pathological response to neoadjuvant chemotherapy. In addition, computed tornography and/or magnetic resonance imaging are useful tools in determining the optimal resection area for breast cancer.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.